Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
Xinyu Li(Tianjin University), Yubin Ge(Wayne State University), Jay Yang(Boston Children's Hospital), Sijana H. Dzinic(Wayne State University), Tristan Knight(Wayne State University), Kathryn White(Wayne State University), Holly Edwards(Wayne State University), Gerard J. Madlambayan(University of Rochester), Lisa Polin(Wayne State University), Juiwanna Kushner(Wayne State University), Yue Wang(Qingdao University), Jun Ma(China Agricultural University), Guan Wang(First Hospital of China Medical University), Jeffrey W. Taub(Wayne State University), Hai Lin(Jilin University), Yongwei Su(Jilin University)
Cited by 68
Related Papers
Alginate hydrogels as synthetic extracellular matrix materials
|Biomaterials|1999|2.3k
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
|The Lancet Oncology|2010|586
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
|Cancer Cell|2018|489
High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model
|Nature Communications|2014|432